Your browser doesn't support javascript.
loading
Reconstruction of Forequarter and Extended Forequarter Amputations: Indications and Outcomes.
Roubaud, Margaret S; Mericli, Alexander F; Adelman, David M; Hanasono, Matthew M; Lewis, Valerae O; Moon, Bryan S.
Afiliação
  • Roubaud MS; From the Departments of Plastic Surgery.
  • Mericli AF; From the Departments of Plastic Surgery.
  • Adelman DM; From the Departments of Plastic Surgery.
  • Hanasono MM; From the Departments of Plastic Surgery.
  • Lewis VO; Orthopaedic Oncology, The University of Texas M. D. Anderson Cancer Center.
  • Moon BS; Orthopaedic Oncology, The University of Texas M. D. Anderson Cancer Center.
Plast Reconstr Surg ; 152(1): 194-205, 2023 07 01.
Article em En | MEDLINE | ID: mdl-36728500
ABSTRACT

BACKGROUND:

Forequarter amputations (FQAs) and extended forequarter amputations (EFQAs) are rare procedures with high morbidity that often require significant soft-tissue or bony reconstruction. The authors describe the largest series of oncologic FQAs and EFQAs to date with associated reconstructive and oncologic outcomes.

METHODS:

The authors retrospectively reviewed data from all patients who underwent FQA or EFQA at The University of Texas M. D. Anderson Cancer Center from January 1, 2008, to January 1, 2019. Surgical outcomes, survival, and local recurrence rates were summarized and compared.

RESULTS:

Forty-seven patients met the inclusion criteria, including 14 with EFQAs. Most patients (53%) were male; the median age was 58 years (range, 2 to 74). The most common tumor type was sarcoma (79%), and the most common presentation was recurrent (34%). Nineteen patients (40%) had distant metastases. The median defect size was 351 cm 2 ; flap reconstruction was required in 30 patients (64%). Eight patients (17%) experienced immediate complications and 12 (26%) experienced delayed complications. The median overall survival (OS) time was 21 months and the 5-year OS rate was 28.1%. OS and disease-free survival were superior in the EFQA group (69.8% versus 11.6%, P = 0.017; 58.9% versus 9.8%, P = 0.014, respectively). Metastasis at presentation was the most important predictor of survival on multivariate analysis (OR, 3.98; P = 0.004).

CONCLUSIONS:

Patients with EFQA had better OS and disease-free survival than did patients with FQA, owing to a lower incidence of metastatic disease. This study suggests a benefit to more aggressive resection and reconstruction when disease is locally confined. CLINICAL QUESTION/LEVEL OF EVIDENCE Therapeutic, III.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Procedimentos de Cirurgia Plástica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Plast Reconstr Surg Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Procedimentos de Cirurgia Plástica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Plast Reconstr Surg Ano de publicação: 2023 Tipo de documento: Article